Do you want to read an article? Please log in or register.
Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study
Lymphoma
Related content
Lymphoma
Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study
Br J Haematol
Severinsen FT, Simonsen MR, Futtrup Maksten E, Jakobsen LH, Jensen RK, Søgaard KK, Jensen P, Brown PN, Mészáros Jørgensen J, Larsen TS, Poulsen CB, El-Galaly TC
doi: 10.1111/bjh.20262
Central Nervous System Tumors
Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study
Lancet Oncol
Hoogendijk R, Capocaccia R, van der Lugt J, Kranendonk MEG, Hoving EW, Wesseling P, Visser O, van Vuurden DG, Gatta G, Karim-Kos HE, EUROCARE working group
doi: 10.1016/S1470-2045(25)00297-9
Lymphoma
A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study
Blood Cancer J
Vaughn JL, Ramdhanny A, Munir M, Rimmalapudi S, Epperla N
doi: 10.1038/s41408-024-01194-5
Lymphoma
Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: an ancillary study from the BLOCAGE trial
Neuro Oncol
Hernández-Verdin I, Kirasic E, Mokhtari K, Barillot N, Rincón de la Rosa L, Sourdeau E, Abada Y, Le Tarff-Tavernier M, Nichelli L, Rozenblum L, Kas A, Mathon B, Choquet S, Houillier C, Hoang-Xuan K, Alentorn A
doi: 10.1093/neuonc/noaf059
COMMENTED
Lymphoma
Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands
★ 1
Recommended and commented by
Dr Andreas Müller, Faculty Member
Leuk Lymphoma
Meeuwes FO, Brink M, van der Poel MWM, Serroukh YIM, Vermaat JSP, Huls GA, de Boer M, de Jong D, Plattel WJ, Nijland M
doi: 10.1080/10428194.2025.2530167
Breast Cancer
Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group
Lancet Oncol
Jensen MB, Torpe E, Teunissen Z, Taarnhøj G, Brix E, Knoop A, Yammeni S, Donskov F, Ejlertsen B
doi: 10.1016/S1470-2045(25)00085-3
Leukemia
Clinical and molecular characteristics of paediatric mature B-cell acute lymphocytic leukaemia and non-Hodgkin lymphoma with bone marrow involvement: A joint study between the CCCG leukaemia and lymphoma groups
Br J Haematol
Zhao J, Liu TF, Wu KF, Yang LC, Xu XJ, Lu J, Shao JB, Li F, Ma FT, Guo X, Li H, Liu AG, Wang NL, Shen HP, Li Y, Liu SX, Liang CD, Shen SH, Fang YJ, Gao YJ
doi: 10.1111/bjh.20011
Lymphoma
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
Hemasphere
Ossami Saidy A, Peczynski C, Thieblemont C, Daskalakis M, Wehrli M, Beauvais D, Finke J, Schorb E, Vandenberghe P, Berning P, Stelljes M, Ayuk F, Ram R, Von Bonin M, Dreger P, Bethge W, Kuhnl A, Jost L, Stölzel F, von Tresckow B, Renner C, Fuhrmann S, Galimard JE, Michel E, Bazarbachi A, Balari AS, Schmitz N, Glass B
doi: 10.1002/hem3.70146
Lung, Respiratory and Thoracic Cancer
Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study
Lung Cancer
Tafur A, Sebai A, Shi Z, Wei J, Tran H, Zheng SL, Krantz S, Hensing T, Mansfield AS, Xu J
doi: 10.1016/j.lungcan.2025.108712